(Q51785440)

12 April 2018

title

Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria. (English)

1 reference

12 April 2018

author

Gregory T. Kitten

3

1 reference

12 April 2018

Michael Bader

12

1 reference

12 April 2018

Ana Cristina Simões E Silva

15

1 reference

12 April 2018

Natalia Alenina

13

object named as

Natalia Alenina

1 reference

12 April 2018

author name string

Sérgio V B Pinheiro

1

1 reference

12 April 2018

Anderson J Ferreira

2

1 reference

12 April 2018

Kátia D da Silveira

4

1 reference

12 April 2018

Deivid A da Silva

5

1 reference

12 April 2018

Sérgio H S Santos

6

1 reference

12 April 2018

Elisandra Gava

7

1 reference

12 April 2018

Carlos H Castro

8

1 reference

12 April 2018

Júnio A Magalhães

9

1 reference

12 April 2018

Renata K da Mota

10

1 reference

12 April 2018

Giancarla A Botelho-Santos

11

1 reference

12 April 2018

Robson A S Santos

14

1 reference

12 April 2018

language of work or name

English

0 references

publication date

4 March 2009

1 reference

12 April 2018

published in

Kidney International

1 reference

12 April 2018

volume

75

1 reference

12 April 2018

issue

11

1 reference

12 April 2018

page(s)

1184-1193

1 reference

12 April 2018

https://scigraph.springernature.com/pub.10.1038/ki.2009.61

exact match

0 references

cites work

Drugs targeting the renin-angiotensin-aldosterone system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Novel angiotensin peptides

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

The therapeutic potential of Angiotensin-(1-7) as a novel Renin-Angiotensin System mediator

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-(1–7) in End-Stage Renal Disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Involvement of angiotensin-(1-7) in the hypothalamic hypotensive effect of captopril in sinoaortic denervated rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Up-regulation of the angiotensin II type 1 receptor by the MAS proto-oncogene is due to constitutive activation of Gq/G11 by MAS

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Evidence that the vasodilator angiotensin-(1-7)-Mas axis plays an important role in erectile function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Plasma renin in mice with one or two renin genes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Why are angiotensin concentrations so high in the kidney?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Effects of angiotensin II and angiotensin-(1-7) on the release of [3H]norepinephrine from rat atria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Molecular physiology of renal aquaporins and sodium transporters: exciting approaches to understand regulation of renal water handling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1–7)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Mechanisms of tubulointerstitial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Toward a unified theory of renal progression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Effect of angiotensin II antagonism on the regression of kidney disease in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Modulation of glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Renal fibrosis: new insights into the pathogenesis and therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Vasodilator effect of angiotensin-(1-7) in mature and sponge-induced neovasculature.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Inhibition of human lung cancer cell growth by angiotensin-(1-7).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

ACE and ACE2 activity in diabetic mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Systemic and regional hemodynamics assessment in rats with fluorescent microspheres.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Validation of fluorescent-labeled microspheres for measurement of regional organ perfusion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Fluorescent microspheres to measure organ perfusion: validation of a simplified sample processing technique.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Growth hormone effects on hypertrophic scar formation: a randomized controlled trial of 62 burned children

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

DARPP-32 and NCS-1 expression is not altered in brains of rats treated with typical or atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.61

7 January 2021

Identifiers

DOI

10.1038/KI.2009.61

1 reference

12 April 2018

1 reference

12 April 2018